TAU THERAPEUTICS

tau-therapeutics-logo

Tau Therapeutics LLC, a development stage biopharmaceutical company, focuses on the research, development, repositioning, and commercialization of calcium T-channel therapy agents as cytostatic anti-cancer drugs. It offers calcium T-channel blockers for oncology and other diseases. The company was founded in 2003 and is based in Charlottesville, Virginia.

#SimilarOrganizations #People #Website #More

TAU THERAPEUTICS

Industry:
Biotechnology Oncology Pharmaceutical Therapeutics

Founded:
2003-01-01

Address:
Charlottesville, Virginia, United States

Country:
United States

Website Url:
http://www.tautherapeutics.com

Total Employee:
1+

Status:
Active

Contact:
434-974-6969

Total Funding:
12.84 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Mobile Non Scaleable Content Microsoft Exchange Online Liquid Web Microsoft DNS


Similar Organizations

arctic-therapeutics-logo

Arctic Therapeutics

Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.

avstera-therapeutics-logo

Avstera Therapeutics

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

geneos-therapeutics-logo

Geneos Therapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

iroko-pharmaceuticals-logo

Iroko Pharmaceuticals

Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.

pinpoint-therapeutics-logo

Pinpoint Therapeutics

Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.

tmunity-therapeutics-logo

Tmunity Therapeutics

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells

vintabio-logo

VintaBio

VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.

Current Employees Featured

timothy-macdonald_image

Timothy Macdonald
Timothy Macdonald Founding Scientist @ Tau Therapeutics
Founding Scientist

not_available_image

Paul H. Sartori
Paul H. Sartori Vice President of Operations and Strategy @ Tau Therapeutics
Vice President of Operations and Strategy

not_available_image

Timothy L. Macdonald
Timothy L. Macdonald Founder and Vice President of Drug Discovery @ Tau Therapeutics
Founder and Vice President of Drug Discovery

bruce-a-silver_image

Bruce A. Silver
Bruce A. Silver Chief Medical Officer @ Tau Therapeutics
Chief Medical Officer

Founder


andrew-j-krouse_image

Andrew J. Krouse

lloyd-gray_image

Lloyd Gray

not_available_image

Timothy L. Macdonald

Official Site Inspections

http://www.tautherapeutics.com

  • Host name: host.mytechtailor.com
  • IP address: 208.75.148.200
  • Location: Lansing United States
  • Latitude: 42.7348
  • Longitude: -84.6245
  • Metro Code: 551
  • Timezone: America/Detroit
  • Postal: 48917

Loading ...

More informations about "Tau Therapeutics"

Tay Therapeutics โ€“ Overcoming mutations, treating disease

We turn discovery into action, advancing differentiated small molecule medicines through in-house expertise and strategic partnerships. Our therapies aim to address serious conditions โ€ฆSee details»

Tau Therapeutics - Crunchbase Company Profile & Funding

Organization. Tau Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Tau Therapeutics engages in the โ€ฆSee details»

Tay Therapeutics Ltd | LinkedIn

Tay Therapeutics is a UK-based biotech headquartered in Dundee, overlooking the River Tay. We are dedicated to developing targeted small molecule therapies to address diseases with high โ€ฆSee details»

Tay Therapeutics - 2025 Company Profile - Tracxn

Tay Therapeutics - Developer of therapeutics for genetic diseases and cancer. Raised a total funding of $1.62M over 3 rounds. Founded by Andrew Woodland and Mark Bell in the year โ€ฆSee details»

Tay Therapeutics Ltd - Drug pipelines, Patents, Clinical trials

Taytherapeutics.com. Holding Company | 2020 | United Kingdom | taytherapeutics.com. Last update 08 May 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. ... The statistics โ€ฆSee details»

Tay Therapeutics | Welcome to Bio-Dundee

[email protected]. Description. Delivering first in class therapies for skin disease. We specialize in the discovery of drugs, which are safe and effective, for the treatment of skin โ€ฆSee details»

TAU Therapeutics Company Profile | Management and Employees โ€ฆ

TAU Therapeutics Profile and History. TAU Therapeutics is a clinical stage biopharmaceutical company committed to providing patients with a better way of treating cancer through the โ€ฆSee details»

About us - Tay Therapeutics

Mark Bell is a medicinal chemist with 20 years experience working in biotech and academic settings. He co-founded Tay Therapeutics and led on the discovery of VYN201, a topical soft โ€ฆSee details»

Tau Therapeutics - Products, Competitors, Financials, Employees ...

Tau Therapeutics is a clinical stage company developing oncology drugs for solid tumors that selectively inhibit the T-type calcium channel - a mechanism of action for cancer. Use the CB โ€ฆSee details»

Tay Therapeutics - Crunchbase Company Profile & Funding

Tay-Enableโ„ข A platform for discovering and developing medicines that enable the body to ignore premature stop codon mutations, producing functional proteins for genetic diseases and cancers.See details»

TAY THERAPEUTICS LIMITED - Companies House

TAY THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business โ€ฆSee details»

Spinout agrees potential $50 million deal - University of Dundee

May 2, 2023 The company has agreed the deal with VYNE Therapeutics Inc, a US-based biotech firm focused on developing therapies for immuno-inflammatory diseases. VYNE has โ€ฆSee details»

Tay Therapeutics Announces Licensing to VYNE Therapeutics of

May 2, 2023 For more information, please visit www.taytherapeutics.com or contact Tim Sparey Ph.D (Executive Chair) [email protected] (+44 (0) 7718864561). About VYNE โ€ฆSee details»

Contact โ€“ Tay Therapeutics

Tay Therapeutics Limited Company number: SC651132. Email: [email protected]. Registered Address Dundee University Incubator 3 James Lindsay PlaceSee details»

Tau Therapeutics - Contacts, Employees, Board Members

Tau Therapeutics engages in the R&D, repositioning and commercialization of calcium T-channel therapies for oncology and other diseases.See details»

Tay Therapeutics Ltd (Tay Therapeutics Ltd) - ่ฏ็‰ฉ็ฎก็บฟ_ไธ“ๅˆฉ_ไธดๅบŠ โ€ฆ

Jun 15, 2025 ไบ†่งฃTay Therapeutics Ltd (Tay Therapeutics Ltd)ๅ…ฌๅธ็š„่ฏ็‰ฉ็ฎก็บฟ๏ผŒๆฒป็–—้ข†ๅŸŸ๏ผŒๆŠ€ๆœฏๅนณๅฐ๏ผŒไปฅๅŠๅฎƒ็š„49็ฏ‡ๆ–ฐ้—ป๏ผŒ็–พ็—…้ข†ๅŸŸ:ๅ…็–ซ็ณป็ปŸ็–พ็—…๏ผŒๅ†…ๅˆ†ๆณŒไธŽไปฃ่ฐข็–พ็—…๏ผŒ็ฅž็ป็ณป็ปŸ็–พ็—…๏ผŒ่‚ฟ โ€ฆSee details»

Tau therapeutics: Clinical development status and future directions ...

Dec 7, 2020 Background. Accumulation of insoluble, misfolded tau protein is a hallmark of AD, chronic traumatic encephalopathy and approximately half of frontotemporal lobar degeneration โ€ฆSee details»

Pipeline โ€“ Tay Therapeutics

TAY-B1 (Repibresib): Locally Active BET Inhibitor. TAY-B1 is a first-in-class, locally active BET bromodomain inhibitor (BRD2, BRD3, BRD4, BRDT) designed to effectively target โ€ฆSee details»

Revisiting the therapeutic landscape of tauopathies: assessing the ...

Jun 4, 2025 Microtubule associated protein tau (MAPT) is a naturally occurring protein that plays a significant role in stabilizing microtubules, which are essential for the transport of nutrients โ€ฆSee details»

Science โ€“ Tay Therapeutics

Restoring Protein Synthesis. In normal cells, mRNA is translated by the ribosome into a chain of amino acids, producing functional proteins. A nonsense mutation introduces a premature stop โ€ฆSee details»

linkstock.net © 2022. All rights reserved